Industry Trends: By The Numbers

Compiled by Cari Kraft, Jacobs Management Group, Inc.

$930M

Amount raised for health-related campaigns on Go F undMe fr om 2010-2016

GoFundMe, the leading crowdfunding site, reported that, of the over $2 billion raised on its site from 2010-2016, $930 million, or about 46.5%, was for health-related campaigns. Source: Nerd Wallet, November 2, 2016

93.11

$93.7B

Oncology market size, largest in healthcare

Oncology continues to be the largest therapy area in the industry, due to new advances in treatments and an aging population. It now has a worldwide market share of 11.7%. Source: EvaluatePharma World Preview 2017, Outlook to 2022

27%

Index of Italy, rated healthiest country in the world

In a survey of countries worldwide, Italy was determined to be the healthiest, based on such factors as life expectancy, causes of death, incidence of high blood pressure, high blood glucose, tobacco use, and physical inactivity. It was followed by Iceland, Switzerland and Singapore. The US came in at #34. Source: Bloomberg Global Health Index, August 2017

Per cent of US Medical Science Liasons (MSL s) who are pharmacists

MSLs can often be PhDs, postdocs or physicians. But in the US, they most commonly have a PharmD degree. In Portugal, 22% are pharmacists, followed by Italy at 9.1% and Spain at 8.8%. Source: FSTP (From Science to Pharma] global MSL salary survey

#13

$59B Position o f Johnson & Johnson among most admired companies in 2017 Fortune magazine rated the best-regarded companies in 51 industries and 28 countries. Johnson & Johnson was the highest-rated healthcare company, coming in at Expected 2020 global value of CRO Market 13 overall, and followed by Roche, Novartis, Merck and The global contract research organization market is Amgen among industry names. expected to reach $59B by 2020, growing at a CAGR of Source: Fortune, World’s Most Admired Companies, 2017 9.80%. Source: Zion Market Research “Contract Research Organization (CRO) Market for Early-Stage Development Services and Last-Stage Development Services: Global Industry Perspective, Comprehensive Analysis and Forecast 2014-2020” June 2017 Rise in Nasdaq biopharma index H1 of 2017 Biopharma companies did well in the first half 17% of the year, rising 17% over 2016 on the Nasdaq Biotechnology Index. S&P Pharmaceuticals showed the sector up 9% and Dow Jones Pharma and Biotech had them up 11%.

Source: EvaluatePharma and Biotech Half-Year

Review, July 2017